Tobam Has $797,000 Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Tobam increased its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 41.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,341 shares of the biotechnology company’s stock after acquiring an additional 395 shares during the period. Tobam’s holdings in Axon Enterprise were worth $797,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. boosted its position in Axon Enterprise by 30.6% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 802 shares of the biotechnology company’s stock worth $236,000 after acquiring an additional 188 shares during the last quarter. Truist Financial Corp boosted its holdings in Axon Enterprise by 53.4% during the second quarter. Truist Financial Corp now owns 6,467 shares of the biotechnology company’s stock worth $1,903,000 after purchasing an additional 2,251 shares during the last quarter. Sanctuary Advisors LLC bought a new position in Axon Enterprise in the second quarter valued at $836,000. Czech National Bank increased its stake in Axon Enterprise by 8.2% in the 3rd quarter. Czech National Bank now owns 14,625 shares of the biotechnology company’s stock valued at $5,844,000 after buying an additional 1,107 shares during the last quarter. Finally, GAMMA Investing LLC raised its stake in shares of Axon Enterprise by 53.9% during the 3rd quarter. GAMMA Investing LLC now owns 985 shares of the biotechnology company’s stock worth $394,000 after purchasing an additional 345 shares in the last quarter. 79.08% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

AXON has been the topic of a number of recent analyst reports. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Northland Securities upped their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Needham & Company LLC boosted their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. JMP Securities increased their price objective on Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a research report on Tuesday. Finally, The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. One research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus target price of $542.15.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $677.40 on Friday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company has a market cap of $51.65 billion, a PE ratio of 175.04, a price-to-earnings-growth ratio of 6.54 and a beta of 1.05. The company has a 50 day moving average of $622.79 and a 200-day moving average of $491.30. Axon Enterprise, Inc. has a 1-year low of $255.68 and a 1-year high of $698.67.

Insider Buying and Selling at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 21,834 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the sale, the insider now directly owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. The trade was a 12.39 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the transaction, the director now directly owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 50,545 shares of company stock worth $30,721,337 over the last three months. Corporate insiders own 5.70% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.